Virpas Tablet
Marketer
Strides shasun Ltd
Salt Composition
Ledipasvir (90mg) + Sofosbuvir (400mg)
Overview Virpas Tablet
HepCease tablets contain a dual antiviral formulation, prescribed for managing chronic hepatitis C (HCV). This medication combats the virus to eliminate the infection. Adhere strictly to the prescribed dosage and duration. Consumption is independent of food, but maintain consistent daily timing. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, such as liver or kidney impairment, to your physician. Alcohol consumption should be minimized or avoided entirely due to potential adverse interactions. Completing the prescribed course is crucial for optimal outcomes. Fatigue and cephalalgia are common, manageable side effects; hydration and a balanced diet are recommended. Always inform your doctor of any concurrent medications or supplements before starting treatment.
Uses of Virpas Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Virpas Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Virpas Tablet. Ingest the tablet whole; do not crush, chew, or divide it. While Virpas Tablet can be taken with or without food, consistent timing is recommended.
Common Side effects of Virpas Tablet:
- Tiredness
- Headache
How to use Virpas Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Virpas Tablet can be consumed with or without food, though consistent timing is recommended.
How Virpas Tablet works:
Virpas Tablet, a dual antiviral therapy containing Ledipasvir and Sofosbuvir, reduces hepatitis C viral load and ultimately eradicates the virus from the bloodstream through sustained treatment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Virpas Tablet lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Virpas Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Virpas Tablet use appear compatible. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Virpas Tablet. Concurrent use of Virpas Tablet with other hepatitis C medications can result in dizziness and blurred vision, potentially impacting driving capabilities.
KidneyCAUTION
Exercise caution when administering Virpas Tablet to individuals with severely impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Data regarding Virpas Tablet use in such patients is limited. No dosage changes are advised for those with mildly or moderately compromised kidney function.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Virpas tablets without requiring any modification to the prescribed dosage.
What if you forget to take Virpas Tablet :
Should you forget to take a Virpas Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Virpas Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently